Registration Links (4 Options)
ONC-ORG

Cancer Drug Encyclopedia

Approved oncology medications — what they treat, how they work and key safety information.

ZirabevBevacizumab
VEGF / VEGFR-2 Angiogenesis InhibitorIntravenous Solution / Subcutaneous Injection

Colorectal Cancer, Non-Small Cell Lung Cancer, Glioblastoma, Renal Cell Carcinoma, Gastric Cancer, and Ovarian Cancer.

View Drug Details & Inquire→
Ziv-AfliberceptZiv-Aflibercept
Targeted Oncology AgentOral Tablet / Capsule

Approved for use in oncology care according to FDA-approved indications.

View Drug Details & Inquire→
ZofranOndansetron Hydrochloride
Antiemetic Supportive Agent (5-HT3 / NK1 Receptor Antagonist)Oral Tablet / Intravenous Solution

Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).

View Drug Details & Inquire→
ZoladexGoserelin Acetate
GnRH / LHRH Agonist or AntagonistSubcutaneous / Intramuscular Depot Injection

Advanced Prostate Cancer and Premenopausal Hormone-Receptor Positive Breast Cancer.

View Drug Details & Inquire→
Zolbetuximab-clzbZolbetuximab-clzb
Targeted Monoclonal AntibodyIntravenous Solution / Subcutaneous Injection

Targeted treatment of solid tumors and hematologic malignancies.

View Drug Details & Inquire→
Zoledronic AcidZoledronic Acid
Bone-Modifying Agent / Bisphosphonate / RANKL InhibitorSubcutaneous Injection / Intravenous Infusion

Prevention of skeletal-related events in patients with bone metastases from solid tumors and multiple myeloma; hypercalcemia of malignancy.

View Drug Details & Inquire→
ZolinzaVorinostat
Targeted Oncology AgentOral Tablet / Capsule

Approved for use in oncology care according to FDA-approved indications.

View Drug Details & Inquire→
ZometaZoledronic Acid
Bone-Modifying Agent / Bisphosphonate / RANKL InhibitorSubcutaneous Injection / Intravenous Infusion

Prevention of skeletal-related events in patients with bone metastases from solid tumors and multiple myeloma; hypercalcemia of malignancy.

View Drug Details & Inquire→
ZyclaraImiquimod
Targeted Oncology AgentOral Tablet / Capsule

Approved for use in oncology care according to FDA-approved indications.

View Drug Details & Inquire→
ZydeligIdelalisib
Targeted Oncology AgentOral Tablet / Capsule

Approved for use in oncology care according to FDA-approved indications.

View Drug Details & Inquire→
ZykadiaCeritinib
ALK / ROS1 Tyrosine Kinase InhibitorOral Film-Coated Tablet / Capsule

ALK-positive and ROS1-positive metastatic Non-Small Cell Lung Cancer.

View Drug Details & Inquire→
ZynlontaLoncastuximab Tesirine-lpyl
Targeted Antibody-Drug Conjugate (ADC)Lyophilized Powder for Intravenous Infusion

Advanced or metastatic solid tumors or hematologic malignancies expressing targeted surface antigens.

View Drug Details & Inquire→